Baricitinib-d4

SL-2799

Baricitinib-d4, >98% (CP)

Isotopic Purity : 98 atom % D

CAS No. : [1564241-99-1]

Synonyms : INCB028050-d4; LY3009104-d4

IUPAC Name : 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile-d4

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
10MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : Baricitinib-d_{4 i}s a deuterium labelled version of Baricitinib, which is a a selective and orally bioavailable JAK1 and JAK2 inhibitor for the treatment of rheumatoid arthritis. Also, this is a COVID-19 related research chemical.

References : Fridman J. S. et al. J. Immunol., 184(9), 5298-5307, 2010; Jabbari A. et al. EBioMedicine 2(4), 351-5, 2015; Khan I. M. et al. Int. J. Obes (Lond). 39(11), 1607-1618, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.